A Review of COVID-19 Mass Testing in the United Arab Emirates

Farida Al-Hosani, Shereena Al-Mazrouei, Shammah Al-Memari, Zain Al-Yafei, Marília Silva Paulo, Erik Koornneef

Research output: Contribution to journalReview articlepeer-review

21 Citations (Scopus)


Appropriate diagnostic testing to identify persons infected with SARS-COV-2 is a vital part of a health system's ability to control the global pandemic of COVID-19 disease. The primary purpose of this review is to provide an overview of the mass testing strategy implemented throughout the UAE and the overall impact it has made on containing and controlling the spread of the disease. This study describes the mass testing strategy and capacity of the UAE during the pandemic of the new coronavirus SARS-COV-2. The UAE has conducted 15 million polymerase chain reaction (PCR) tests to SARS-COV-2, as of 15 November 2020. The number of tests per day varied from 10,000 by the end of March to 120,000 tests per day in November 2020. The mass testing initiative across the entire UAE forms an integral part of a bigger strategy focusing on testing, tracing contacts and isolating positive cases.

Original languageEnglish
Article number661134
JournalFrontiers in Public Health
Publication statusPublished - May 12 2021


  • COVID-19
  • SARS-CoV-2
  • United Arab Emirates
  • mass testing strategy
  • public health policy
  • public health strategy

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'A Review of COVID-19 Mass Testing in the United Arab Emirates'. Together they form a unique fingerprint.

Cite this